DC Medic
ActiveDC Medic has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €329k and a net result of €158k. Its solvency ranks better than 89% of 19906 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).
Checked score
Score 2024
95
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency100▲+5
Growth52
Track record94
Bankruptcy probability, 12 months
0.3%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30k at 30 days acceptable
Liquidity ample (current ratio 26.46 against 3.36 in 2023; short-term debt: 3.4% and cash: 85.9% of total assets), and 6.1% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
93.9%
Return on assets
45.1%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 21-06-2025, 40 days ahead of the deadline.
NBB · 2 filingsDeviation from the deadline
2025
not confirmed
2024
40 d early
2023
7 d late
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€329k▲ 92.5%
2023 · €171k
2023: €171k
2023 → 2024
Total assets
€350k▲ 43.6%
2023 · €244k
2023: €244k
2023 → 2024
Net result
€158k▼ 5.5%
2023 · €167k
2023: €167k
2023 → 2024
Working capital
€299k▲ 124%
2023 · €133k
2023: €133k
2023 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20232024Trend
Equity€171k-€329k▲ 92.5%
Operating result€220k-€208k▼ 5.8%
Net result€167k-€158k▼ 5.5%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 6% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €350k
Fixed assets
€39k▼ 26.8%
Current assets
€311k▲ 63.5%
Equity and liabilities €350k
Equity
€329k▲ 92.5%
Debt
€21k▼ 70.9%
The debt ratio falls from 29.9% to 6.1%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€222k▼
2023 · €237k
Cash flow
€172k▼
2023 · €184k
Solvency
93.9%▲
2023 · 70.1%
Current ratio
26.46▲
2023 · 3.36
Quick ratio
26.46▲
2023 · 3.36
Debt / equity
0.06▼
2023 · 0.43
ROE
48.1%▼
2023 · 98.0%
ROA
45.1%▼
2023 · 68.6%
Interest coverage
116.38▼
2023 · 165.20
Debt
€21k▼
2023 · €73k
Debt ≤ 1 year
€12k▼
2023 · €57k
Debt > 1 year
€10k▼
2023 · €16k
Income taxes
€48k▼
2023 · €52k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€244k€350k▲
Fixed assets21/28€54k€39k▼
Tangible fixed assets22/27€54k€39k▼
Plant, machinery and equipment23€23k€17k▼
Furniture and vehicles24€30k€23k▼
Current assets29/58€190k€311k▲
Amounts receivable within one year40/41-€4k
Trade receivables40-€650
Other amounts receivable41-€4k
Cash at bank and in hand54/58€185k€301k▲
Deferred charges and accrued income490/1€5k€6k▲
Equity and liabilities
Total equity and liabilities10/49€244k€350k▲
Equity10/15€171k€329k▲
Contributions10/11€4k€4k=
Profit (loss) carried forward14€167k€325k▲
Amounts payable17/49€73k€21k▼
Amounts payable after more than one year17€16k€10k▼
Financial debts170/4€16k€10k▼
Amounts payable within one year42/48€57k€12k▼
Current portion of amounts payable after more than one year42€7k€7k▲
Trade debts44€9k€5k▼
Suppliers440/4€9k€5k▼
Taxes, remuneration and social security45€7k-
Taxes450/3€2k-
Remuneration and social security454/9€5k-
Other amounts payable47/48€34k-
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€17k€14k▼
Other operating charges640/8€1k€494▼
Gross operating margin9900€238k€223k▼
Operating profit (loss)9901€220k€208k▼
Financial income75/76B-€0
Recurring financial income75-€0
Financial charges65/66B€1k€2k▲
Recurring financial charges65€1k€2k▲
Profit (loss) for the period before taxes9903€219k€206k▼
Income taxes67/77€52k€48k▼
Profit (loss) for the period9904€167k€158k▼
Profit (loss) for the period to be appropriated9905€167k€158k▼
Appropriation of the result
Profit (loss) to be appropriated9906€167k€325k▲
Profit (loss) brought forward from the previous period14P-€167k
The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
21-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity times 8current ratio 26.46
Current ratio from 3.36 to 26.46; short-term debt falls from €57k to €12k.
31-12
Financial
Equity above €200kEq €329k ▲92.5%
2 profitable years in a row build equity to €329k.
07-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 7 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Watermaal-Bosvoorde · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Gaailaan 231170 Watermaal-BosvoordeGround area
569 m²
Building footprint
105 m²
Volume, LiDAR
992 m³
Parcel 21017D0243/00V003, Brussels · tallest building 14.7 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
DC Medic
since 20222.332.586.714
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21017D0243/00V003 | Brussels | 569 m² | 1 · 105 m² | 14.7 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
ERNALIX Med
BE 0808.336.533
Charleroi · Eq €329k
Dokter Lode Van Gossum
BE 0790.516.049
Heist-op-den-Berg · Eq €329k
DR. FATTIZZO
BE 0480.223.442
Maasmechelen · Eq €329k
Dokter Kris Vanderlinden
BE 0455.881.093
Nazareth-De Pinte · Eq €329k
CABINET MEDICAL JEAN-LOUIS MARCHAND
BE 0825.321.926
Brunehaut · Eq €328k
Of 9,120 companies in sector 86210 we hold annual accounts for 6,336. 5,180 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded17-06-2022
Fiscal year end31-12
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 2 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.
Contact details
2 entriesE-mail:daeninckmartin@gmail.com
E-mail:mathilde.coers@gmail.com